Panantiviral agents : implications for treating cancers associated with oncoviruses
Tweetable abstract Panantiviral agents have emerged as a promising class of drugs for cancer therapy, targeting multiple oncoviruses simultaneously. Challenges include drug resistance, safety and developing specific inhibitors. Future research should focus on viral transcription regulators and new panantivirals. #cancer #oncovirus #panantiviral #drugresistance.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
|---|---|
| Enthalten in: |
Future medicinal chemistry - 15(2023), 11 vom: 01. Juni, Seite 909-912 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Siddiqui, Amna [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antiviral Agents |
|---|
| Anmerkungen: |
Date Completed 16.08.2023 Date Revised 16.08.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.4155/fmc-2023-0117 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM357300807 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM357300807 | ||
| 003 | DE-627 | ||
| 005 | 20231226072303.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.4155/fmc-2023-0117 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1190.xml |
| 035 | |a (DE-627)NLM357300807 | ||
| 035 | |a (NLM)37227720 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Siddiqui, Amna |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Panantiviral agents |b implications for treating cancers associated with oncoviruses |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 16.08.2023 | ||
| 500 | |a Date Revised 16.08.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Tweetable abstract Panantiviral agents have emerged as a promising class of drugs for cancer therapy, targeting multiple oncoviruses simultaneously. Challenges include drug resistance, safety and developing specific inhibitors. Future research should focus on viral transcription regulators and new panantivirals. #cancer #oncovirus #panantiviral #drugresistance | ||
| 650 | 4 | |a Editorial | |
| 650 | 4 | |a antiviral therapy | |
| 650 | 4 | |a medicinal chemistry | |
| 650 | 4 | |a microbiology | |
| 650 | 4 | |a molecular biology | |
| 650 | 4 | |a strains | |
| 650 | 4 | |a treatment | |
| 650 | 4 | |a virology | |
| 650 | 7 | |a Antiviral Agents |2 NLM | |
| 700 | 1 | |a Aaqil, Syeda Ilsa |e verfasserin |4 aut | |
| 700 | 1 | |a Jawed, Areesha |e verfasserin |4 aut | |
| 700 | 1 | |a Haider, Ramsha |e verfasserin |4 aut | |
| 700 | 1 | |a Ochani, Sidhant |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Future medicinal chemistry |d 2009 |g 15(2023), 11 vom: 01. Juni, Seite 909-912 |w (DE-627)NLM194822109 |x 1756-8927 |7 nnns |
| 773 | 1 | 8 | |g volume:15 |g year:2023 |g number:11 |g day:01 |g month:06 |g pages:909-912 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.4155/fmc-2023-0117 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 15 |j 2023 |e 11 |b 01 |c 06 |h 909-912 | ||